Background The number of market approvals of orphan medicinal products (OMPs) has
been increasing steadily in the last 3 decades. While OMPs can offer a unique chance for …

Background Access to essential medicines for the world's poor and vulnerable has made
little progress since 2000, except for a few specific medicines such as antiretrovirals for …

Considerable progress has been made in cancer drug development in recent decades.
However, for people in low-and middle-income countries, including Malaysia, many of these …

The possibility of editing the genomes of human embryos has generated significant
discussion and interest as a matter of science and ethics. While it holds significant promise …

ABSTRACT In 2008 the UN Special Rapporteur on the Right to Health published 72 right to
health indicators in 194 health systems. We present a follow-up report of eight indicators for …

Persistent barriers to universal access to medicines are limited social protection in the event
of illness, inadequate financing for essential medicines, frequent stock-outs in the public …

La utilización de la vía judicial para asegurar y garantizar el acceso a insumos médicos
constituye una de las estrategias más efectivas para asegurar el cumplimiento (o remediar …

Universal health coverage (UHC) aims to ensure that all people have access to health
services including essential medicines without risking financial hardship. Yet, in many low …

Rare diseases are an important global public health issue. One significant challenge is to
ensure the access to orphan drugs for patients with rare disease. This study aims to evaluate …

Uruguay has witnessed an ever-increasing number of domestic court claims for high-priced
medicines despite its comprehensive universal coverage of pharmaceuticals. In response to …